We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breaking the 1 Angstrom Imaging Barrier

By Biotechdaily staff writers
Posted on 08 Apr 2004
A new 200 kv transmission electron microscope (TEM) allows images for the first time to be directly viewed with a resolution of less than one angstrom, using commercially available technologies.

One angstrom is one-tenth of a nanometer in size, and a nanometer is one billionth of a meter. More...
One angstrom is also about one-third the size of a carbon atom and is a key dimension for atomic-level research. Now, scientists at FEI Company (Hillsboro, OR, USA) have broken the 1 angstrom high resolution imaging barrier with this new microscope.

The ability to attain direct artifact-free images of atoms opens the doors for researchers working in nanotechnology development to explore materials at the highest resolution ever. The sub-Angstrom resolution was achieved by using FEI's Tecnai F20 transmission electron microscope employing technologies that improve image resolution with advanced electron optics capabilities developed by FEI and its partner, CEOS Company (Corrected Electron Optical Systems, Heidelberg, Germany). This permits novel TEM techniques, such as 3D reconstruction with tomography, scanning probe applications, or in situ observation of specimen responses to variations in temperature, stress, or chemical environment--all with sub-Angstrom resolutions.

"The successful use of an electron beam monochromator to improve the resolution of a Cs-corrected electron microscope marks a major milestone for the field of electron microscopy,” said Dr. Michael O'Keefe of the U.S. National Center of Electron Microscopy (Berkeley, CA, USA). "Theory has long predicted that a monochromator would be able to push the resolution of the super-twin lens beyond the 1.4A resolution demonstrated with the Cs-correction alone.”

FEI Company provides advanced tools for a range of nanotechnology markets, including materials science, life science, semiconductors, and data storage. Its products enable researchers and manufacturers to fabricate and modify nanoscale structures and to view and characterize them in three dimensions down to the atomic level.




Related Links:
FEI Company

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.